Cleared Traditional

K892645 - AMICON VITAFIBER FLO-PATH BIORECT/VLS CELL CULT SY (FDA 510(k) Clearance)

Class I Pathology device.

K892645 · Amicon, Inc. · Pathology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1989
Decision
62d
Days
Class 1
Risk

K892645 is an FDA 510(k) clearance for the AMICON VITAFIBER FLO-PATH BIORECT/VLS CELL CULT SY. Classified as System, Suspension, Cell Culture (product code KJF), Class I - General Controls.

Submitted by Amicon, Inc. (Danvers, US). The FDA issued a Cleared decision on June 13, 1989 after a review of 62 days - a notably fast clearance cycle.

This device falls under the Pathology FDA review panel, regulated under 21 CFR 864.2240 - the FDA pathology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Amicon, Inc. devices

Submission Details

510(k) Number K892645 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 12, 1989
Decision Date June 13, 1989
Days to Decision 62 days
Submission Type Traditional
Review Panel Pathology (PA)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
15d faster than avg
Panel avg: 77d · This submission: 62d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code KJF System, Suspension, Cell Culture
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 864.2240
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.